ENYO Pharma Alternatives & Competitors
12 companies similar to ENYO Pharma — Developing therapeutics for diseases with impaired kidney function
Companies similar to ENYO Pharma
GENFIT
Dedicated to improving the lives of patients with liver diseases characterized by high unm...
ILIAS Biologics Inc.
The Global Leader in Exosome-based Therapeutics
KAMADA
Specialty Plasma-Derived Therapeutics
AusperBio
Transforming Patient Lives For a Better Tomorrow
Rival Readout
Competing with ENYO Pharma? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
REGENXBIO
Seeking to improve lives through the curative potential of gene therapy.
Arch Biopartners Inc (ARCH:TSXV) (ACHFF:OTCQB)
A late stage clinical trial company focused on the development of novel therapeutics targe...
Biodexa Pharmaceuticals PLC
Advancing Medicines for a Brighter Future
Emmaus Life Sciences, Inc
Improving the lives of people with rare disease.
DevsHealth
At DevsHealth, we leverage our advanced DeepTech platform to enhance the development of an...
MOGAM Institute for Biomedical Research
Advancing global health with AI-driven therapies for rare diseases, autoimmune disorders,...
Angitia Biopharmaceuticals
Developing innovative medicines to address serious musculoskeletal diseases
About ENYO Pharma
ENYO Pharma is a biopharmaceutical company that focuses on developing therapeutics for diseases with impaired kidney function. The company's lead compound, Vonafexor, is currently undergoing Phase 2 trials for Chronic Kidney Diseases (CKD), rare kidney diseases such as Alport syndrome, and liver diseases, including Non...
Developing therapeutics for diseases with impaired kidney function
Patients with impaired kidney function, pharmaceutical companies, research institutions
Biopharmaceuticals, Therapeutics, Chronic Kidney Diseases, Rare Kidney Diseases, Liver Diseases, Infectious Diseases, Vonafexor, Intracellular Therapeutic Targets, Anti-virals, Drug Development, Phase 2 Trials, Research And Development, Inserm Patents, Viral Treatments, Global Leader
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around ENYO Pharma: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at ENYO Pharma on 11 Jun 2025. The 12 companies listed here were last checked between 11 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.